DegenRx is a biotech company developing AAV-mediated gene therapy for the treatment of Alzheimer’s disease. Using Adeno-Associated-Viral (AAV) vectors we deliver genes in the brain that initiate the local production of therapeutic antibodies
| Website | http://www.degenrx.com |
| Employees | 3 (0 on RocketReach) |
| Founded | 2018 |
| Technologies |
JavaScript
,
HTML
,
PHP
+8 more
(view full list)
|
| Industry | Biotechnology, Pharmaceutical Manufacturing, Science and Engineering, Drug Discovery, Pharmaceutical, Health Care |
| Keywords | Gene Therapy, Aav Gene Therapy, Biotech, Therapeutic Antibodies, Adeno Associated Virus, Drug Development, Neurodegenerative Diseases, Pharmaceutical, Biotechnology, Drug Discovery, Gene Delivery, Clinical Trials, Therapeutic Proteins, Precision Medicine |
Looking for a particular DegenRx B.V. employee's phone or email?
DegenRx B.V. is based in Tilburg, Noord-Brabant.